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The ability of a home-made aqueous extract of Aloe barbadensis to prevent the onset of alloxan-
induced hyperglycaemia was examined and compared with that of a factory-produced gel. Three groups 
of animals were administered 200 mg/kg body weight of alloxan intraperitoneally. A fourth group of 
animals was left uninjected.  Animals in group 2 also received a uniform administration of 1 mg/ml twice 
daily oral intake of Aloe gel (the home-made extract) commenced at the same time the alloxan was 
administered and continued thereafter for the next six days. Animals in group 3 were administered the 
factory-produced extract in a similar way as was done for animals in group 2. Plasma glucose levels at 
the end of the experiment were 142.50±6.28, 82.50±2.72, 88.17±1.92 and 94.17±1.51mg/dl for animals in 
groups 1, 2, 3 and 4, respectively. Alloxan administration possibly resulted in an increase of 51% in the 
plasma glucose level of animals in group 1 relative to animals in group 4 (p<0.05).  The results suggest 
that both the home-made and the factory-produced extracts prevented the onset of hyperglycaemia 
with the home-made extract appearing to be more potent.  
 





Aloe barbadensis has been documented to ameliorate 
the diabetic condition in human and experimental sub-
jects (Ghannam, 1986; Ajabnoor, 1990; Koo, 1994; Okyar 
et al, 2001).  Other health benefits of this much publicized 
“miracle plant” (Gjerstad and Riner, 1968) have been 
clearly highlighted by the scientific community and the 
practitioners of alternative and herbal medicine (Winters 
et al, 1981; Danhof and McAnally, 1983; Bland, 1985; 
Danhof, 1987; Pittman, 1992).  
Aloe gel and other products form the plant are produc-
ed industrially for commercial purposes and there is a 
large and ready market for these. However the plant is 
also increasingly being homegrown and individuals prep-
are home remedies from it to treat various ailments. 
Many individuals also use Aloe as a prophylactic. It is 
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purpose of general well being.  
In this study, the inhibitory effects of a home-made 
extract and a factory-produced one on the onset of hyper-
glycaemia in rabbits treated with alloxan were compared 
in order to ascertain whether Aloe prevents hyperglyca-
emia when it is administered simultaneously with the 
hyperglycaemic agent. This study also aims at comparing 
the effectiveness of the much publicized and often 
expensive industrially made Aloe products with that of 
home-made preparations by individuals. This will give a 
clue as to whether Aloe  could  be  used  for  preventive 
therapy and not just for curative purposes as is mostly 
the case at present and will also provide a basis for the 
justification or otherwise for encouragement to individuals 
to personally prepare and use Aloe. 
 
 




Alloxan was obtained form  Sigma  Chemical  Company  St.  Louis,  















Figure 1. Fasting plasma glucose levels of rabbits treated with alloxan and extracts of aloe. 
A = Alloxan; A+HMA = alloxan + home-made aloe; A+FPA = alloxan + factory-produced aloe; 




USA.  Glucose oxidase, peroxidase and 4-aminophenazone were 
obtained from Biotech Laboratories, Surrey, UK. All other reagents 
were of analytical grade.  
 
 
Animals and tratement  
 
Male albino rabbits (1.0 - 1.5 kg) were obtained form the 
Agricultural Farm, University of Ibadan, Nigeria. The animals were 
housed under standardized environmental conditions and were fed 
standard diet and water ad libitum. The animals were randomly 
divided into four groups of six animals each. Animals in group 1 
received an intraperitoneal administration of 200 mg/kg body weight 
alloxan. Animals in groups 2 and 3 received the same dose of 
alloxan and a twice-daily oral intake of the home-made and the 
industrially-prepared Aloe, respectively, commencing from the time 
the alloxan was administered and thereafter throughout the duration 
of the experiment (7 days). Animals in group 4 did not receive any 
special treatment.  
 
 
Preparation of extract  
 
The home-made extract was prepared as described previously 
(Akinmoladun and Akinloye, 2004). The whole gel was used.  This 
was made to a concentration of 50% i.e. 1 g/ml (w/v) and this dose 
was administered twice daily to animals in group 2.  The factory-
produced extract was obtained from Forever Living Products, USA 
and was labeled as 100% Aloe vera gel containing 3% sodium, 4% 
total carbohydrate, 0% total fat, sugars and protein with unspecified 
amounts of the following additives and preservatives: sorbitol, 
ascorbic acid, citric acid, potassium sorbate, sodium benzoate, 
xanthan gum and tocopherol.  
 
 
Preparation of plasma  
 
Blood was collected form the dorsal veins of the ear lobes of the 
animals into tubes containing EDTA (Akinmoladun and Akinloye, 
2004). Plasma was prepared by centrifugation for 10 min at 3000 g 
using an MSE bench centrifuge.  The supernatant obtained was 
used for the estimation of the concentration of glucose.  
 
 
Glucose assay  
 
Portions of the plasma were assayed for glucose by the glucose 
oxidase method of Trinder (1969).  
 
 
Statistical analysis  
 
The results were expressed as means ± SEM. The significance 
between means was determined using the student’s t-test and 




RESULTS AND DISCUSSION 
 
Alloxan administration seemed to have led to an increase 
of 51% in the plasma glucose level of rabbits in group 1 
relative to the control (group 4) (P<0.05) since there were 
no other factors that could have been responsible.  Both 
the home-made and industrially-prepared gels prevented 
the onset of hyperglycaemia as could be seen by a 
comparison of the fasting plasma glucose (FPG) 
concentrations of animals in group 2 (alloxan + home-
made Aloe) and group 3 (alloxan + industrially-prepared 
Aloe) with that of animals in group 1 (alloxan only) 
(Figure 1).   
Plasma glucose levels for animals in group 2 and 3 
were lower than that for the control (group 4). However, 
while the difference between plasma glucose levels for 
animals in group 4 (94.17±1.5 1mg/dl) and animals in 
group 3 (88.17±1.92 mg/dl) was not significant (p>0.05); 
that between the animals in group 4 and those in group 2 
(82.50±2.72 mg/dl) was significant (p<0.05) (Figure 1). 
This probably suggests that the use of the home-made 
preparation portends the risk of hypoglycaemia, espe-
cially in a normoglycaemic subject. It may be stated 
therefore that although the difference in the plasma 
glucose levels of animals in groups 2 and 3 was not 
statistically significant (P>0.05), the blood glucose-
lowering action of the home-made extract seemed to be 
more pronounced than that of the factory-produced one, 
more so when the concentration of the home-made 
extract was just half of that of the factory produced one.  
The hypoglycaemic action of the extracts of A. 
barbadensis was established by this study as has been 
demonstrated by other workers (Ajabnoor, 1990; Koo, 
1994; Akinmoladun and Akinloye, 2004).  Much emphasis 
has been on the curative and ameliorative effect of A. 
barbadensis on hyperglycaemia and diabetes. Findings 
from the present work suggest that Aloe may be able to 
prevent these diseased states. Since the simultaneous 
administration of A. barbadensis and the hyperglycaemic  




agent inhibited hyperglycaemia, it is reasonable to 
postulate that pre-treatment with A. barbadensis before 
alloxan administration will also produce a similar effect. 
This therefore encourages the prophylactic use of the 
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